Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- DGFT Notifies New SION A-3685 Under FTP 2023
- DGFT Launches Helpdesk to Support Exporters & Importers
- DGFT Amends ANF-4J Declarations for Diamond Imprest Authorisation (DIA)
- DGFT Invites Feedback on SIONs for Automobile Tyres.
- Deadline for Filing Annual RODTEP Return (ARR) for FY 2023-24 Extended to 30th June 2025
- Advance Authorisation License Norms Fixation: Everything You Need to Know in 2025
- Advance License Authorisation Amendment: Latest Updates and Simplified Guide (2025)
- Bombay High Court Rules: No Interest or Penalty on IGST for Past Imports under Advance Authorisation
FeATURED ARTICLES
DGFT Notifies New SION A-3685 Under FTP 2023 We’re pleased to inform our readers that the Directorate General of Foreign…
DGFT Launches Helpdesk to Support Exporters & Importers In response to the evolving global trade environment—marked by shifting tariffs, import…
DGFT Amends ANF-4J Declarations for Diamond Imprest Authorisation (DIA) The Director General of Foreign Trade (DGFT) has made key amendments…
DGFT Invites Feedback on SIONs for Automobile Tyres. The Directorate General of Foreign Trade (DGFT) has initiated a review of…
